Last weeks round-up; 10 – 14 February 2020
published 18 Feb 2020
HPRA IN IRELAND HAS ANNOUNCED THE PHASED ENDING OF THE USE AND LEARN PERIOD FOR THE IMPLEMENTATION OF THE SAFETY FEATURES REQUIREMENTS FROM THE FALSIFIED MEDICINES LEGISLATION (FMD)
The Safety Features Oversight Group in Ireland (which comprises the Irish Medicines Verification Organisation (IMVO), Department of Health, Health Products Regulatory Authority (HPRA), Pharmaceutical Society of Ireland (PSI), Health Service Executive (HSE) and Private Hospitals Association (PHA), has agreed that the use and learn period for the Safety Features requirements will end in a phased approach.
The 3 detailed phases commencing 2nd March 2020, are;
- Parallel imported and parallel distributed from Primary Wholesalers – from 2nd March 2020
- All wholesalers – from May 2020, precise date to be notified
- Pharmacies, hospitals and all others who supply medicines to the public – from Sept 2020, precise date to be notified.
Further details and definitions can be found here (https://lnkd.in/dhkfSUu).